This will allow for developing novel dietary strategies for improving insulin sensitivity and reducing the risk of metabolic disorders by modulating carbohydrate metabolism in the gut, central to the whole-body glucose homeostasis. The gene discussed is INS; the disease is Other metabolic disease.